Combination of IG-IMRT and permanent source prostate brachytherapy in patients with organ-confined prostate cancer: GU and GI toxicity and effect on erectile function.
Valakh
Vladimir
V
Department of Radiation Oncology, Allegheny General Hospital, Pittsburgh, PA 15212, USA.
Kirichenko
Alexander
A
Miller
Ralph
R
Sunder
Tara
T
Miller
Lindsay
L
Fuhrer
Russell
R
D000368:Aged; D001918:Brachytherapy / Q000009:adverse effects*; D003131:Combined Modality Therapy / Q000009:adverse effects; D005767:Gastrointestinal Diseases / Q000209:etiology* / Q000517:prevention & control; D006801:Humans; D008297:Male; D052801:Male Urogenital Diseases / Q000209:etiology* / Q000517:prevention & control; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D011832:Radiation Injuries / Q000209:etiology* / Q000517:prevention & control; D020266:Radiotherapy, Conformal / Q000009:adverse effects*; D016896:Treatment Outcome